MAIA Biotechnology, Inc.
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Nov 5, 2026 (10 days)
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Feb 21, 2023 | Noble Capital Markets | initiate | — → Outperform | $14 | 63% |
No cross-platform signals in the last 90 days